Actively Recruiting
Impact of Bright Light Therapy on Prader-Willi Syndrome
Led by Maimonides Medical Center · Updated on 2026-04-24
50
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
Sponsors
M
Maimonides Medical Center
Lead Sponsor
F
Foundation for Prader-Willi Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
CONDITIONS
Official Title
Impact of Bright Light Therapy on Prader-Willi Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Prader-Willi Syndrome confirmed by genetic testing
- Score of 12 or above on the Epworth Sleepiness Scale (ESS)
- Age between 6 and 18 years old
You will not qualify if you...
- Eye conditions that could be worsened by bright light or use of photosensitizing medications
- Previous treatment with light therapy
- Active psychosis or mania
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219
Actively Recruiting
Research Team
M
Mayank Kumar, PhD
CONTACT
T
Theresa Jacob, MPH, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here